Bosutinib usage instructions

Bosutinib (Bosutinib) is a targeted drug used to treat chronic myelogenous leukemia (CML). It effectively blocks the proliferation and spread of leukemia cells by inhibiting the activity of the BCR-ABL protein. However, to ensure optimal efficacy and patient safety, correct use is crucial.

1. Dosage requirements:

1. Usual dosage for adults: 400 mg orally once daily for newly diagnosed patients. Patients in chronic phase/accelerated phase/acute phase should take 500 mg orally once daily.

2. Common dosage for children: 300mg/m² for newly diagnosed patients, taken orally once a day. For patients in the chronic phase who are resistant or intolerant to previous treatments: 400mg/m², taken orally once daily.

2. Dosage method: Bosutinib is usually administered orally, once a day, with food.

3. Taking time: In order to ensure the stability and efficacy of the medicine, it is recommended that patients take medicine at a fixed time every day to avoid missing doses or overdosing. Do not stop using it without your doctor's advice.

4. How to take: Bosutinib should be swallowed whole and should not be chewed or ground before taking. For patients who are unable to swallow bosutinib capsules directly, we have a special method to help them take the medication easily. First, remove the required number of capsules from the vial and determine the required dosage according to your doctor's instructions. Next, prepare room temperature applesauce or yogurt in a clean container. We then need to open each capsule very carefully, making sure all the powder in each capsule is poured into the applesauce or yogurt. Afterwards, use a mixing tool to thoroughly mix the medication powder with the applesauce or yogurt until the medication is completely dissolved. The patient should drink the mixture immediately without chewing. Be careful not to save the mixture for later use. If you are unable to swallow the entire mixture at once, do not increase the dose on your own. Instead, wait until the next day and continue taking your regular dose.

5. If you miss a dose or overdose: If you miss a dose, take it as quickly as possible, but if you take it more than 12 hours late, skip the missed dose. In case of overdose, seek medical attention immediately.

In short, bosutinib is an effective drug for the treatment of chronic myelogenous leukemia. Patients must strictly follow the doctor's instructions when using it to ensure the best efficacy of the drug and patient safety. At present, bosutinib is only sold overseas. The specific selling price varies depending on the version. Patients are asked to choose according to their needs.